Performance of the extended use of the FilmArray^® BCID panel kit for bronchoalveolar lavage analysis

Area of Science:

• Clinical Microbiology
• Infectious Diseases
• Critical Care Medicine

Background:

• Ventilator-associated pneumonia (VAP) significantly increases patient morbidity, mortality, and hospital stays.
• Early and accurate diagnosis of VAP is critical for effective antimicrobial therapy and improved clinical outcomes.
• Multiplex PCR kits offer potential for rapid pathogen identification.

Purpose of the Study:

• To evaluate the diagnostic performance of the FilmArray® BCID panel for detecting bacterial pathogens in bronchoalveolar lavage (BAL) fluid from VAP patients.
• To compare the FilmArray® BCID panel results against conventional culture-based methods.

Main Methods:

• A prospective study involving 50 BAL samples from intensive care unit patients.
• Samples were analyzed using the FilmArray® BCID panel and standard culture methods.
• Performance metrics including sensitivity and specificity were calculated.

Main Results:

• The FilmArray® BCID panel demonstrated high specificity (98.9%) for VAP detection in BAL fluid.
• Sensitivity varied: 67.2% overall, 88.6% for cultures >10^4 CFU/mL, and 94.7% for positive direct examination.
• The panel provided reliable results early, especially with positive direct examination findings.

Conclusions:

• The FilmArray® BCID panel exhibits good performance for analyzing BAL fluid in VAP diagnosis.
• Early results from the panel, particularly when direct examination is positive, facilitate timely antimicrobial treatment adjustments.
• This molecular approach supports rapid adaptation of therapy, potentially improving VAP patient management.